同: GCA

WordNet

cause to grow together parts from different plants; "graft the cherry tree branch onto the plum tree" (同)engraft, ingraft
the act of grafting something onto something else (同)grafting
(surgery) tissue or organ transplanted from a donor to a recipient; in some cases the patient can be both donor and recipient (同)transplant
(botany) the trumpet-shaped or cup-shaped outgrowth of the corolla of a daffodil or narcissus flower
one or more circles of light seen around a luminous object
a long cigar with blunt ends
(anatomy) any structure that resembles a crown in shape
surrounding like a crown (especially of the blood vessels surrounding the heart); "coronary arteries"
sclerosis of the arterial walls (同)arterial sclerosis, hardening of the arteries, induration of the arteries, coronary-artery disease

PrepTutorEJDIC

ground-controlled approach地上からの誘導着陸[装置]
(つぎ木の)つぎ穂;つぎ木 / (皮被・内臓・骨などの)移植片 / (木に)〈つぎ穂〉‘を'つぐ,(体に)〈移植片〉‘を'移植する《+『名』+『on』(『upon』,『in』,『into』)+『名』》 / …‘を'結合させる《+『名』+『together』》 / (…に)つぎ木する,移植する《+『on』(『upon』,『in』,『into』)+『名』》
収賄,汚職;贈賄;〈C〉汚職で得たもの / 汚職する,収賄する
コロナ(皆既日食のときに見える光冠) / (太陽・月などの)かさ
冠状動脈の / 心臓の / 冠状動脈血栓(けっせん)症(coronary thrombosis)
動脈硬化[症]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 低侵襲冠動脈バイパス術：定義および技術的な問題 minimally invasive coronary artery bypass graft surgery definitions and technical issues
2. 冠動脈バイパス術：大伏在静脈グラフトの狭窄の予防およびマネージメント coronary artery bypass graft surgery prevention and management of vein graft stenosis
3. 冠動脈バイパス術：長期的臨床転帰 coronary artery bypass graft surgery long term clinical outcomes
4. オフポンプ低浸襲直接的冠動脈バイパス手術：転帰 off pump and minimally invasive direct coronary artery bypass graft surgery outcomes
5. 冠動脈バイパス術後の後期再発性狭心症 late recurrent angina pectoris after coronary artery bypass graft surgery

English Journal

Spinal Cord Ischemia/Injury.

Ishikawa T, Suzuki H, Ishikawa K, Yasuda S, Matsui T, Yamamoto M, Kakeda T, Yamamoto S, Owada Y, Yaksh TL.Author information Division of Neurosciences, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-kogushi, Ube, Yamaguchi, 755-8505, Japan. medlibn@yamaguchi-u.ac.jp.AbstractOpioids; i.e., compounds with morphine-like actions, and their receptors have been demonstrated to be involved in cardioprotection, at least in scientific studies, which makes sense as cardiomyocytes express most of the known opioid receptors and their agonists. In vitro and in vivo studies have demonstrated that the opioid system plays various important roles in maintaining cardiac function; i.e., it influences cardiac rhythm, cell stress, and even developmental processes. In support of these research findings, there is also good clinical evidence that opioids are effective as cardioprotective drugs. In fact, in the American College of Cardiology Foundation/American Heart Association (ACCF/AHA) guidelines for coronary artery bypass graft surgery opioids and volatile halogenated anesthetics are referred to as anti-ischemic or conditioning agents. Although opioids are administered to all patients who undergo surgery as well as patients admitted to the ICU, including those that suffer heart attacks, no recommendations about their use for the preconditioning/management of myocardial ischemia have been included in recent clinical guidelines due to the weak clinical evidence about their effects. Opioids have been used as pain control agents in the clinical setting for a long time. As such, surgical, critical care, and cancer patients routinely receive them. On the other hand, ischemic heart disease continues to be a leading cause of morbidity and mortality in developed countries, and opioid therapy might be useful for treating the condition. This review examines recent clinical trials of the effects of opioids on ischemic heart disease and discusses the barriers to the use of opioids for cardioprotection.
Current pharmaceutical design.Curr Pharm Des.2014 Feb 3. [Epub ahead of print]
Opioids; i.e., compounds with morphine-like actions, and their receptors have been demonstrated to be involved in cardioprotection, at least in scientific studies, which makes sense as cardiomyocytes express most of the known opioid receptors and their agonists. In vitro and in vivo studies have dem
PMID 24502574

Cardioprotection with Opioids- Trusted Old Friends -Clinical Science -

Ishii H.Author information Department of Anesthesia, Tenri Hospital, 200 Mishima-cho, Tenri, Nara 632-8555, Japan. hisanari@tenriyorozu.jp.AbstractOpioids; i.e., compounds with morphine-like actions, and their receptors have been demonstrated to be involved in cardioprotection, at least in scientific studies, which makes sense as cardiomyocytes express most of the known opioid receptors and their agonists. In vitro and in vivo studies have demonstrated that the opioid system plays various important roles in maintaining cardiac function; i.e., it influences cardiac rhythm, cell stress, and even developmental processes. In support of these research findings, there is also good clinical evidence that opioids are effective as cardioprotective drugs. In fact, in the American College of Cardiology Foundation/American Heart Association (ACCF/AHA) guidelines for coronary artery bypass graft surgery opioids and volatile halogenated anesthetics are referred to as anti-ischemic or conditioning agents. Although opioids are administered to all patients who undergo surgery as well as patients admitted to the ICU, including those that suffer heart attacks, no recommendations about their use for the preconditioning/management of myocardial ischemia have been included in recent clinical guidelines due to the weak clinical evidence about their effects. Opioids have been used as pain control agents in the clinical setting for a long time. As such, surgical, critical care, and cancer patients routinely receive them. On the other hand, ischemic heart disease continues to be a leading cause of morbidity and mortality in developed countries, and opioid therapy might be useful for treating the condition. This review examines recent clinical trials of the effects of opioids on ischemic heart disease and discusses the barriers to the use of opioids for cardioprotection.
Current pharmaceutical design.Curr Pharm Des.2014 Feb 3. [Epub ahead of print]
Opioids; i.e., compounds with morphine-like actions, and their receptors have been demonstrated to be involved in cardioprotection, at least in scientific studies, which makes sense as cardiomyocytes express most of the known opioid receptors and their agonists. In vitro and in vivo studies have dem
PMID 24502567

Gender-specific aspects of cardiovascular disease.

Roberts BH.Author information Director, The Women's Cardiac Center at The Miriam Hospital and Associate Clinical Professor of Medicine, Alpert Medical School of Brown University.AbstractWhen William Heberden gave his classic description of angina pectoris in 1768, he inadvertently described a gender-specific difference in heart disease when he noted the predominance of men with this condition. It is only in the last few decades that the medical profession has recognized that women are equally afflicted with atherosclerotic cardiovascular disease, albeit with some differences in presentation, risk factors and outcomes. This article will detail the ways in which men and women differ when it comes to the number one killer in the developed, and increasingly the developing, world. [Full text available at http://rimed.org/rimedicaljournal-2014-02.asp, free with no login].
Rhode Island medical journal (2013).R I Med J (2013).2014 Feb 3;97(2):19-22.
When William Heberden gave his classic description of angina pectoris in 1768, he inadvertently described a gender-specific difference in heart disease when he noted the predominance of men with this condition. It is only in the last few decades that the medical profession has recognized that women
PMID 24494209

Japanese Journal

History and Current Status of Robotic Totally Endoscopic Coronary Artery Bypass

LEE Jeffrey D.,SRIVASTAVA Mukta,BONATTI Johannes
Circulation journal : official journal of the Japanese Circulation Society 76(9), 2058-2065, 2012-08-25
… Robotic totally endoscopic coronary artery bypass (TECAB) is a minimally invasive endoscopic surgical approach using the daVinci robotic telemanipulation system to perform coronary artery bypass grafting on the arrested or beating heart. … After extensive modeling in cadavers, the first clinical case was performed in June 1998 placing a left internal thoracic artery graft (LITA) to the left anterior descending artery completely robotically on the arrested heart. …
NAID 10030696074

長期開存を目指したヒト冠動脈バイパス血管のセロトニン反応性に関する薬理学的研究

田中直子
YAKUGAKU ZASSHI 129(9), 1049-1053, 2009
… In ischemic heart diseases, the use of the internal thoracic artery (ITA) as an arterial graft has been associated with longer survival and better quality of life. … However, it has been reported that vasospasm of the ITA graft frequently occurs and increases perioperative and postoperative morbidity. …
NAID 130000136002

術後対麻痺をきたした待機的腹部大動脈瘤手術例の検討

福田幸人,木川幾太郎,三浦友二郎,宮入剛
日本心臓血管外科学会雑誌 37(3), 201-204, 2008-05-15
非破裂腹部大動脈瘤(AAA)に対する待機的手術において,術後対麻痺を合併した希な2例を経験したので報告する.症例1は80歳の透析施行中の男性で,術前の冠動脈造影検査で左前下行枝に75%の狭窄を認めたが,心機能良好であるためAAAに対し後腹膜アプローチによりtubeグラフト置換術を行った.術直後より対麻痺症状を認め,術後のMRIで前脊髄動脈症候群と診断された.症例2は62歳の男性で,術前に心拍動下で …
NAID 110006666458